Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Longhorn Vaccines and Diagnostics

Longhorn Vaccines and Diagnostics Validates Efficacy of PrimeStore® Molecular Transport Medium (MTM) to Inactivate Deadly Pathogens
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics Presents Compelling Data on LHNVD-303 Vaccine for Sepsis Related to Bacterial Infections at the World Vaccine Congress
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics to Present Data on Single and Dual Peptide Universal Influenza Candidates at ESCMID 2025
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics Honors World TB Day 2025, Underscoring a Commitment to Eradicating Tuberculosis with PrimeStore® MTM
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics Provides Mid-Year Progress on Vaccine and Diagnostic Divisions
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics to Present Data on LHNVD-105, a Universal Vaccine Candidate, at ECCMID 2024
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress on Advantages of Single Peptide Vaccine for Broad Coverage of Human and Avian Influenza Viruses
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics Presents Data Demonstrating Durability of LHNVD-105 Universal Influenza Vaccine in Animal Models at IDWeek 2023
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics Announces Data Showing PrimeStore® Molecular Transport Medium Inactivates High Consequence Animal Viruses
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics Presents Data Demonstrating Neutralizing Activity of LHNVD-201 for Covid-19 and Influenza Co-Infections
From Longhorn Vaccines and Diagnostics
Via Business Wire
Longhorn Vaccines and Diagnostics to Present Durability Data of Peptide-Based Vaccine LHNVD-201 for Covid-19 and Influenza Co-Infections at 17th Vaccine Congress
From Longhorn Vaccines and Diagnostics
Via Business Wire
New Study in The Journal of Applied Laboratory Medicine Supports the Advantages of Longhorn’s PrimeStore MTM® With the Roche cobas Liat® System for SARS-CoV-2 and Influenza Detection
From Longhorn Vaccines and Diagnostics
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.